NPs Basic Information

Name
Secalonic acid D
Molecular Formula C32H30O14
IUPAC Name*
methyl (3S,4R,4aR)-7-[(5R,6S,10aR)-1,5,9-trihydroxy-10a-methoxycarbonyl-6-methyl-8-oxo-6,7-dihydro-5H-xanthen-2-yl]-4,8,9-trihydroxy-3-methyl-1-oxo-3,4-dihydro-2H-xanthene-4a-carboxylate
SMILES
C[C@H]1CC(=O)C2=C(C3=C(C=CC(=C3O)C4=C(C5=C(C=C4)O[C@]6([C@@H]([C@H](CC(=O)C6=C5O)C)O)C(=O)OC)O)O[C@]2([C@@H]1O)C(=O)OC)O
InChI
InChI=1S/C32H30O14/c1-11-9-15(33)21-25(37)19-17(45-31(21,27(11)39)29(41)43-3)7-5-13(23(19)35)14-6-8-18-20(24(14)36)26(38)22-16(34)10-12(2)28(40)32(22,46-18)30(42)44-4/h5-8,11-12,27-28,35-40H,9-10H2,1-4H3/t11-,12-,27+,28+,31+,32+/m0/s1
InChIKey
NFZJAYYORNVZNI-OCHURCMPSA-N
Synonyms
Secalonic acid D; 35287-69-5; HZP8L3M5ME; SECALONSAURE D; methyl (3S,4R,4aR)-7-[(5R,6S,10aR)-1,5,9-trihydroxy-10a-methoxycarbonyl-6-methyl-8-oxo-6,7-dihydro-5H-xanthen-2-yl]-4,8,9-trihydroxy-3-methyl-1-oxo-3,4-dihydro-2H-xanthene-4a-carboxylate; Secalonic acid D mycotoxin; dimethyl (5R,5'R,6S,6'S,10aR,10'aR)-1,1',5,5',8,8'-hexahydroxy-6,6'-dimethyl-9,9'-dioxo-5,5',6,6',7,7',9,9'-octahydro-10aH,10'aH-[2,2'-bixanthene]-10a,10'a-dicarboxylate; CCRIS 4937; SAD; UNII-HZP8L3M5ME; NSC 159631; NSC-159631; NSC-268922; ERGOCHROME EE; Ergochrome AA (2,2')-5-beta,6-alpha,10-beta-5',6'-alpha,10'-beta; (7,7'-Bi-4aH-xanthene)-4a,4'a-dicarboxylic acid, 2,2',3,3',4,4',9,9'-octahydro-1,1',4,4',8,8'-hexahydroxy-3,3'-dimethyl-9,9'-dioxo-, dimethyl ester, (3S-(3-alpha,4-beta,4a-beta,7(3'R,4'S,4'aS))); CHEMBL3740350; CHEBI:144225; (7,7'-BI-4AH-XANTHENE)-4A,4'A-DICARBOXYLIC ACID, 2,2',3,3',4,4',9,9'-OCTAHYDRO-1,1',4,4',8,8'-HEXAHYDROXY-3,3'-DIMETHYL-9,9'-DIOXO-, DIMETHYL ESTER, (3S-(3.ALPHA.,4.BETA.,4A.BETA.,7(3'R*,4'S*,4'AS*)))-; Secalonic acid D 50 microg/mL in Chloroform; Q27095651; (7,7'-BI-4AH-XANTHENE)-4A,4'A-DICARBOXYLIC ACID, 2,2',3,3',4,4',9,9'-OCTAHYDRO-1,1',4,4',8,8'-HEXAHYDROXY-3,3'-DIMETHYL-9,9'-DIOXO-, DIMETHYL ESTER, (3S,3'S,4R,4'R,4AR,4'AR)-; methyl (3S,4R,4aR)-7-[(5R,6S,10aR)-1,5,8-trihydroxy-10a-methoxycarbonyl-6-methyl-9-oxo-6,7-dihydro-5H-xanthen-2-yl]-1,4,8-trihydroxy-3-methyl-9-oxo-3,4-dihydro-2H-xanthene-4a-carboxylate
CAS 35287-69-5
PubChem CID 73431
ChEMBL ID CHEMBL3740350
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Benzopyrans
        • Subclass: 1-benzopyrans
          • Direct Parent: Xanthenes

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 638.6 ALogp: 3.1
HBD: 6 HBA: 14
Rotatable Bonds: 5 Lipinski's rule of five: Rejected
Polar Surface Area: 227.0 Aromatic Rings: 6
Heavy Atoms: 46 QED Weighted: 0.266

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.856 MDCK Permeability: 0.00000874
Pgp-inhibitor: 0.59 Pgp-substrate: 0.996
Human Intestinal Absorption (HIA): 0.672 20% Bioavailability (F20%): 0.044
30% Bioavailability (F30%): 0.882

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.008 Plasma Protein Binding (PPB): 86.27%
Volume Distribution (VD): 0.792 Fu: 7.71%

ADMET: Metabolism

CYP1A2-inhibitor: 0.009 CYP1A2-substrate: 0.839
CYP2C19-inhibitor: 0.012 CYP2C19-substrate: 0.204
CYP2C9-inhibitor: 0.017 CYP2C9-substrate: 0.107
CYP2D6-inhibitor: 0.007 CYP2D6-substrate: 0.133
CYP3A4-inhibitor: 0.627 CYP3A4-substrate: 0.263

ADMET: Excretion

Clearance (CL): 3.408 Half-life (T1/2): 0.041

ADMET: Toxicity

hERG Blockers: 0.024 Human Hepatotoxicity (H-HT): 0.965
Drug-inuced Liver Injury (DILI): 0.962 AMES Toxicity: 0.023
Rat Oral Acute Toxicity: 0.919 Maximum Recommended Daily Dose: 0.032
Skin Sensitization: 0.069 Carcinogencity: 0.023
Eye Corrosion: 0.003 Eye Irritation: 0.006
Respiratory Toxicity: 0.077
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000954 1.000 D01XWG 0.282
ENC000983 1.000 D0T5XN 0.281
ENC003816 0.879 D07VLY 0.278
ENC003347 0.654 D0C9XJ 0.278
ENC005885 0.649 D01XDL 0.276
ENC003348 0.638 D0FX2Q 0.260
ENC001991 0.628 D07IPB 0.254
ENC001973 0.588 D0J2NK 0.250
ENC003346 0.571 D01UBX 0.247
ENC002105 0.552 D0G3DL 0.247
*Note: the compound similarity was calculated by RDKIT.